Jessica PyhtilainLazarus AIFDA Approves Combination Treatment for BPH SymptomsBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Mar 10, 2022----
Jessica PyhtilainLazarus AIFDA Approves New Orally Disintegrating Dosage Form of GlycopyrrolateBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Feb 17, 2022----
Jessica PyhtilainLazarus AIFDA Approves Novel PCSK9 Inhibitor Inclisiran (Leqvio)By Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Jan 31, 2022----
Jessica PyhtilainLazarus AIFDA Approves Rivaroxaban in an Oral Suspension Dosage FormBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Dec 28, 2021----
Jessica PyhtilainLazarus AIFDA Approves Atogepant As Newest CGRP Antagonist for Migraine PreventionBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Oct 12, 2021----
Jessica PyhtilainLazarus AIFDA Approves Ergot-Derivative Nasal Spray to Treat Acute MigraineBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Oct 7, 2021----
Jessica PyhtilainLazarus AIFatal Opioid Overdoses Skyrocket During COVID-19 LockdownsThe CDC recently published an advisory stating that overdoses from synthetic opioids, generally fentanyl, and psychostimulants have…2 min read·Oct 5, 2021----
Jessica PyhtilainLazarus AIScreening Colonoscopy Best Practices ReleasedBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Oct 1, 2021----
Jessica PyhtilainLazarus AIUsing Short and Long-Acting Insulin Together Does Not Increase Cardiovascular Events or MortalityBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Sep 29, 2021----
Jessica PyhtilainLazarus AITreatment Guidelines Released For Cancer PainBy Jessica Pyhtila, PharmD, BCGP, BCPS2 min read·Sep 27, 2021----